Correlation Between Institute and Aileron Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Institute and Aileron Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Institute and Aileron Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Institute of Biomedical and Aileron Therapeutics, you can compare the effects of market volatilities on Institute and Aileron Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Institute with a short position of Aileron Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Institute and Aileron Therapeutics.

Diversification Opportunities for Institute and Aileron Therapeutics

-0.74
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Institute and Aileron is -0.74. Overlapping area represents the amount of risk that can be diversified away by holding Institute of Biomedical and Aileron Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aileron Therapeutics and Institute is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Institute of Biomedical are associated (or correlated) with Aileron Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aileron Therapeutics has no effect on the direction of Institute i.e., Institute and Aileron Therapeutics go up and down completely randomly.

Pair Corralation between Institute and Aileron Therapeutics

Given the investment horizon of 90 days Institute of Biomedical is expected to generate 2.29 times more return on investment than Aileron Therapeutics. However, Institute is 2.29 times more volatile than Aileron Therapeutics. It trades about 0.1 of its potential returns per unit of risk. Aileron Therapeutics is currently generating about -0.04 per unit of risk. If you would invest  0.55  in Institute of Biomedical on September 12, 2024 and sell it today you would earn a total of  0.25  from holding Institute of Biomedical or generate 45.45% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy98.44%
ValuesDaily Returns

Institute of Biomedical  vs.  Aileron Therapeutics

 Performance 
       Timeline  
Institute of Biomedical 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Institute of Biomedical are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak technical and fundamental indicators, Institute unveiled solid returns over the last few months and may actually be approaching a breakup point.
Aileron Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Aileron Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of inconsistent performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Institute and Aileron Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Institute and Aileron Therapeutics

The main advantage of trading using opposite Institute and Aileron Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Institute position performs unexpectedly, Aileron Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aileron Therapeutics will offset losses from the drop in Aileron Therapeutics' long position.
The idea behind Institute of Biomedical and Aileron Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Bonds Directory
Find actively traded corporate debentures issued by US companies
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities